Novo Nordisk claimed Wednesday that it has greater the availability of the lowest dose of its blockbuster weight loss drug Wegovy, which it says allows more and more people from the U.S. to begin taking the drug. And facts released in 2024 on medication, such as semaglutide and tirzepatide, indicated that individuals with diabetic issues who took … Read More